NR1H4 and Impaired glucose tolerance: found that metformin can effectively prevent and treat impaired glucose tolerance and IR by inhibiting intestinal the Farnesoid X receptor (FXR) signal through the gut microbiome in a non-AMP-activated protein kinase (AMPK)-dependent manner (73).